1,374
Views
9
CrossRef citations to date
0
Altmetric
Rheumatology: Original article

A cost-effectiveness analysis of celecoxib compared with diclofenac in the treatment of pain in osteoarthritis (OA) within the Swedish health system using an adaptation of the NICE OA model

, , &
Pages 677-684 | Accepted 06 Jun 2014, Published online: 30 Jun 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Viktor V Chirikov, Chris Walker, Jennifer M Stephens, Patricia Schepman, Richard Chambers, Mahmoud Bakir, Gregory W Poorman, Seema Haider & Mohammed Farghaly. (2021) Evaluating the Cost-Effectiveness of Celecoxib versus Ibuprofen and Naproxen in Patients with Osteoarthritis in United Arab Emirates Based on the PRECISION Trial. ClinicoEconomics and Outcomes Research 13, pages 409-420.
Read now

Articles from other publishers (8)

Jiayu Shi, Kenan Fan, Lei Yan, Zijuan Fan, Fei Li, Guishan Wang, Haifeng Liu, Peidong Liu, Hongmei Yu, Jiao Jiao Li & Bin Wang. (2022) Cost Effectiveness of Pharmacological Management for Osteoarthritis: A Systematic Review. Applied Health Economics and Health Policy 20:3, pages 351-370.
Crossref
Xueshan Sun, Xuemei Zhen, Xiaoqian Hu, Yuanyuan Li, ShuYan Gu, Yuxuan Gu, Zixuan Zhao, Wei Yang & Hengjin Dong. (2021) Cost-utility analysis of imrecoxib compared with diclofenac for patients with osteoarthritis. Cost Effectiveness and Resource Allocation 19:1.
Crossref
Ting Zhao, Hasnat Ahmad, Barbara Graaff, Qing Xia, Tania Winzenberg, Dawn Aitken & Andrew J. Palmer. (2021) Systematic Review of the Evolution of Health‐Economic Evaluation Models of Osteoarthritis. Arthritis Care & Research 73:11, pages 1617-1627.
Crossref
Chiranjeev Sanyal, Justin P. Turner, Philippe Martin & Cara Tannenbaum. (2020) Cost‐Effectiveness of Pharmacist‐Led Deprescribing of NSAIDs in Community‐Dwelling Older Adults . Journal of the American Geriatrics Society 68:5, pages 1090-1097.
Crossref
E. Losina, I.M. Usiskin, S.R. Smith, J.K. Sullivan, K.C. Smith, D.J. Hunter, S.P. Messier, A.D. Paltiel & J.N. Katz. (2018) Cost-effectiveness of generic celecoxib in knee osteoarthritis for average-risk patients: a model-based evaluation. Osteoarthritis and Cartilage 26:5, pages 641-650.
Crossref
Livia Puljak, Ana Marin, Davorka Vrdoljak, Filipa Markotic, Ana Utrobicic & Peter Tugwell. (2017) Celecoxib for osteoarthritis. Cochrane Database of Systematic Reviews 2017:7.
Crossref
Payam Mohammadinejad, Pantea Arya, Mohsen Esfandbod, Ahmad Kaviani, Masoome Najafi, Ladan Kashani, Atefeh Zeinoddini, Seyed Amirhossein Emami & Shahin Akhondzadeh. (2015) Celecoxib Versus Diclofenac in Mild to Moderate Depression Management Among Breast Cancer Patients. Annals of Pharmacotherapy 49:9, pages 953-961.
Crossref
Bei Li, Kaiming Su, Guang Yang, Yanmei Feng, Li Xia & Shankai Yin. (2015) Assessment of the Potential Ototoxicity of High‐Dose Celecoxib, a Selective Cyclooxygenase‐2 Inhibitor, in Rats. Otolaryngology–Head and Neck Surgery 152:6, pages 1108-1112.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.